ZA200403614B - Controlled release tablets of metformin. - Google Patents

Controlled release tablets of metformin.

Info

Publication number
ZA200403614B
ZA200403614B ZA200403614A ZA200403614A ZA200403614B ZA 200403614 B ZA200403614 B ZA 200403614B ZA 200403614 A ZA200403614 A ZA 200403614A ZA 200403614 A ZA200403614 A ZA 200403614A ZA 200403614 B ZA200403614 B ZA 200403614B
Authority
ZA
South Africa
Prior art keywords
metformin
controlled release
release tablets
tablets
controlled
Prior art date
Application number
ZA200403614A
Other languages
English (en)
Inventor
Manish Chawla
Rajeev S Raghuvanshi
Ashok Rampal
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of ZA200403614B publication Critical patent/ZA200403614B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA200403614A 2001-11-06 2004-05-12 Controlled release tablets of metformin. ZA200403614B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1134DE2001 2001-11-06

Publications (1)

Publication Number Publication Date
ZA200403614B true ZA200403614B (en) 2005-01-14

Family

ID=11097132

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200403614A ZA200403614B (en) 2001-11-06 2004-05-12 Controlled release tablets of metformin.

Country Status (9)

Country Link
US (1) US20030104059A1 (zh)
EP (1) EP1465612A1 (zh)
KR (1) KR20050043765A (zh)
CN (1) CN1700910A (zh)
EA (1) EA200400628A1 (zh)
HU (1) HUP0402058A3 (zh)
PL (1) PL369328A1 (zh)
WO (1) WO2003039527A1 (zh)
ZA (1) ZA200403614B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1515701B1 (en) * 2002-06-17 2014-09-17 Inventia Healthcare Private Limited Process for the manufacture of multilayer tablet compositions comprising thiazolidinedione and biguanide
WO2004110422A1 (en) * 2003-06-16 2004-12-23 Ranbaxy Laboratories Limited Extended-release tablets of metformin
WO2005092293A1 (en) * 2004-03-22 2005-10-06 Ranbaxy Laboratories Limited Formulations of metformin
US20060088594A1 (en) * 2004-10-08 2006-04-27 Pilgaonkar Pratibha S Highly compressible controlled delivery compositions of metformin
AU2010319438B2 (en) * 2009-11-13 2015-05-21 Astrazeneca Uk Limited Reduced mass metformin formulations
US11974971B2 (en) 2011-01-07 2024-05-07 Anji Pharmaceuticals Inc. Compositions and methods for treating metabolic disorders
WO2013103384A1 (en) 2012-01-06 2013-07-11 Elcelyx Therapeutics, Inc. Biguanide compositions and methods of treating metabolic disorders
US11759441B2 (en) 2011-01-07 2023-09-19 Anji Pharmaceuticals Inc. Biguanide compositions and methods of treating metabolic disorders
US8796338B2 (en) 2011-01-07 2014-08-05 Elcelyx Therapeutics, Inc Biguanide compositions and methods of treating metabolic disorders
US9480663B2 (en) 2011-01-07 2016-11-01 Elcelyx Therapeutics, Inc. Biguanide compositions and methods of treating metabolic disorders
US9211263B2 (en) 2012-01-06 2015-12-15 Elcelyx Therapeutics, Inc. Compositions and methods of treating metabolic disorders
HUE051738T2 (hu) 2011-01-07 2021-03-29 Anji Pharma Us Llc Kemoszenzoros receptorligandum-alapú terápiák
US9572784B2 (en) 2011-01-07 2017-02-21 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
BR112014016810A8 (pt) 2012-01-06 2017-07-04 Elcelyx Therapeutics Inc composições e métodos para tratamento de distúrbios metabólicos
WO2016042567A1 (en) * 2014-09-16 2016-03-24 Suresh Pareek Extended release formulation of metformin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4432757A1 (de) * 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
ES2248908T7 (es) * 1997-06-06 2014-11-24 Depomed, Inc. Formas de dosificación de fármacos por vía oral y retención gástrica para liberación continuada de fármacos altamente solubles
AU736951C (en) * 1998-03-19 2003-02-20 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
DK1140027T3 (da) * 1998-12-23 2006-02-27 Alza Corp Doseringsformer indeholdende poröse partikler
ES2392705T3 (es) * 2000-10-02 2012-12-13 Usv Ltd. Composiciones farmacéuticas de liberación sostenida que contienen metformina y método para su producción

Also Published As

Publication number Publication date
EP1465612A1 (en) 2004-10-13
HUP0402058A3 (en) 2006-04-28
PL369328A1 (en) 2005-04-18
CN1700910A (zh) 2005-11-23
EA200400628A1 (ru) 2004-12-30
HUP0402058A2 (hu) 2005-02-28
KR20050043765A (ko) 2005-05-11
WO2003039527A1 (en) 2003-05-15
US20030104059A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
IL161525A0 (en) Modified release tamsulosin tablets
AU2002327068A1 (en) Immediate release tablet
AU2002301845A1 (en) Modified release tamsulosin tablets
TWI347202B (en) Controlled release preparation
ZA200204020B (en) Use of anti-CTLA-4-antibodies.
EP1581160A4 (en) ENCAPSULATION PRODUCTS PROVIDING CONTROLLED OR PROLONGED DELIVERY
MXPA03009229A (es) Microcapsulas.
ZA200409617B (en) Microcapsule formulations.
AU2002363360A1 (en) Dual controlled release dosage form
HK1051639A1 (en) Buckle.
HUP0500004A3 (en) Extended release pharmaceutical tablet of metformin
EP1372614A4 (en) SULPHONYL UREA FORMULATION WITH CONTROLLED RELEASE
ZA200403614B (en) Controlled release tablets of metformin.
IL163887A0 (en) Controlled release dosage forms
EP1335708A4 (en) METFORMIN COMPOSITIONS WITH CONTROLLED RELEASE
IL162019A0 (en) Mousse
GB0124338D0 (en) Biochips
EP1457204A4 (en) SHAPED PRODUCT OF RELEASE CONTROL TYPE
GB0115761D0 (en) Capsules
AU2002363392A1 (en) Controlled release tablets of metformin
HK1050120A1 (en) Watchband.
GB2375521B (en) Davits
ZA200305944B (en) Novel modified release formulation.
ZA200104935B (en) Extended release buccal tablet.
AU2002343227A1 (en) Modified release tamsulosin tablets